These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29526446)

  • 1. Analytical Comparability Assessments of 5 Recombinant CRM
    Hickey JM; Toprani VM; Kaur K; Mishra RPN; Goel A; Oganesyan N; Lees A; Sitrin R; Joshi SB; Volkin DB
    J Pharm Sci; 2018 Jul; 107(7):1806-1819. PubMed ID: 29526446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and immunological characterization of
    Mishra RPN; Yadav RSP; Jones C; Nocadello S; Minasov G; Shuvalova LA; Anderson WF; Goel A
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29875175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of sulphydryl oxidase and protein disulphide isomerase in Escherichia coli allows for production of soluble CRM
    Roth R; van Zyl P; Tsekoa T; Stoychev S; Mamputha S; Buthelezi S; Crampton M
    J Appl Microbiol; 2017 May; 122(5):1402-1411. PubMed ID: 28276616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.
    Gao F; Lockyer K; Burkin K; Crane DT; Bolgiano B
    Hum Vaccin Immunother; 2014; 10(9):2744-53. PubMed ID: 25483488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli.
    Park AR; Jang SW; Kim JS; Park YG; Koo BS; Lee HC
    PLoS One; 2018; 13(7):e0201060. PubMed ID: 30021008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Diphtheria Toxin Variant, CRM 197 was Obtained in Escherichia coli at High Productivity Using SUMO Fusion and an Adjusted Expression Strategy.
    Tarahomjoo S; Bandehpour M; Aghaebrahimian M; Ahangaran S
    Protein Pept Lett; 2022; 29(4):350-359. PubMed ID: 35139782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM
    Beresford NJ; Martino A; Feavers IM; Corbel MJ; Bai X; Borrow R; Bolgiano B
    Vaccine; 2017 Jun; 35(28):3598-3606. PubMed ID: 28408122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid.
    Porro M; Saletti M; Nencioni L; Tagliaferri L; Marsili I
    J Infect Dis; 1980 Nov; 142(5):716-24. PubMed ID: 6780629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates.
    Bröker M
    Hum Vaccin Immunother; 2016 Mar; 12(3):664-7. PubMed ID: 26327602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
    Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
    Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression, purification and characterization of diphtheria toxin mutant CRM197 in Eschrichia coli].
    Fang T; Tao Z; Liu Y; Yu C; Zhi R; Yu R
    Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):561-568. PubMed ID: 29701029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines.
    Pecetta S; Vijayakrishnan B; Romano MR; Proietti D; Lo Surdo P; Balocchi C; Mori E; Davis BG; Berti F
    Vaccine; 2016 Mar; 34(11):1405-11. PubMed ID: 26845738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli.
    Stefan A; Conti M; Rubboli D; Ravagli L; Presta E; Hochkoeppler A
    J Biotechnol; 2011 Dec; 156(4):245-52. PubMed ID: 21889551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy.
    Crane DT; Bolgiano B; Jones C
    Eur J Biochem; 1997 Jun; 246(2):320-7. PubMed ID: 9208920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.
    Uthailak N; Mahamad P; Chittavanich P; Yanarojana S; Wijagkanalan W; Petre J; Panbangred W
    Mol Biotechnol; 2017 May; 59(4-5):117-127. PubMed ID: 28324209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-yield production of recombinant CRM197, a non-toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli.
    Goffin P; Dewerchin M; De Rop P; Blais N; Dehottay P
    Biotechnol J; 2017 Jul; 12(7):. PubMed ID: 28397983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines.
    Ho MM; Bolgiano B; Corbel MJ
    Vaccine; 2000 Nov; 19(7-8):716-25. PubMed ID: 11115692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomeric crystal structure of the vaccine carrier protein CRM
    Gallagher DT; Oganesyan N; Lees A
    Acta Crystallogr F Struct Biol Commun; 2023 Apr; 79(Pt 4):82-86. PubMed ID: 36995122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
    Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
    Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.